Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Kitaku, Okayama, Japan.
PLoS One. 2021 Nov 12;16(11):e0259633. doi: 10.1371/journal.pone.0259633. eCollection 2021.
Antimicrobial stewardship for outpatients with acute respiratory tract infections (ARTIs) should be urgently promoted in this era of antimicrobial resistance. Previous large-sample studies were based on administrative data and had limited reliability. We aimed to identify current antimicrobial prescription practices for ARTIs by directly basing on medical records. This multicenter retrospective study was performed from January to December in 2018, at five medical institutes in Japan. We targeted outpatients aged ≥18 years whose medical records revealed International Classification of Diseases (ICD-10) codes suggesting ARTIs. We divided the eligible cases into three age groups (18-64 years, 65-74 years, and ≥75 years). We defined broad-spectrum antimicrobials as third-generation cephalosporins, macrolides, fluoroquinolones, and faropenem. Primary and secondary outcomes were defined as the proportion of antimicrobial prescriptions for the common cold and other respiratory tract infections, respectively. Totally, data of 3,940 patients were collected. Of 2,914 patients with the common cold, 369 (12.7%) were prescribed antimicrobials. Overall, compared to patients aged ≥75 years (8.5%), those aged 18-64 years (16.6%) and those aged 65-74 years (12.1%) were frequently prescribed antimicrobials for the common cold (odds ratio [95% confidential interval]; 2.15 [1.64-2.82] and 1.49 [1.06-2.09], respectively). However, when limited to cases with a valid diagnosis of the common cold by incorporating clinical data, no statistical difference was observed among the age groups. Broad-spectrum antimicrobials accounted for 90.2% of the antimicrobials used for the common cold. Of 1,026 patients with other respiratory infections, 1,018 (99.2%) were bronchitis, of which antimicrobials were prescribed in 49.9% of the cases. Broad-spectrum antimicrobials were the main agents prescribed, accounting for nearly 90% of prescriptions in all age groups. Our data suggested a favorable practice of antimicrobial prescription for outpatients with ARTIs in terms of prescribing proportions, or quantitative aspect. However, the prescriptions were biased towards broad-spectrum antimicrobials, highlighting the need for further antimicrobial stewardship in the outpatient setting from a qualitative perspective.
在当前抗菌药物耐药的时代,迫切需要推广针对急性呼吸道感染(ARTI)门诊患者的抗菌药物管理。先前的大样本研究基于行政数据,可靠性有限。我们旨在通过直接基于病历来确定当前针对 ARTI 的抗菌药物处方实践。这项多中心回顾性研究于 2018 年 1 月至 12 月在日本的五家医疗机构进行,纳入年龄≥18 岁、病历中显示国际疾病分类(ICD-10)编码提示 ARTI 的门诊患者。我们将符合条件的患者分为三组(18-64 岁、65-74 岁和≥75 岁)。我们将广谱抗菌药物定义为第三代头孢菌素、大环内酯类、氟喹诺酮类和 faropenem。主要和次要结局分别定义为普通感冒和其他呼吸道感染的抗菌药物处方比例。共收集了 3940 例患者的数据。在 2914 例普通感冒患者中,有 369 例(12.7%)处方了抗菌药物。总体而言,与≥75 岁的患者(8.5%)相比,18-64 岁(16.6%)和 65-74 岁(12.1%)的患者更常因普通感冒而处方抗菌药物(比值比[95%置信区间];2.15[1.64-2.82]和 1.49[1.06-2.09])。然而,当将临床数据纳入纳入普通感冒的有效诊断时,各年龄组之间无统计学差异。广谱抗菌药物占普通感冒所用抗菌药物的 90.2%。在 1026 例其他呼吸道感染患者中,1018 例(99.2%)为支气管炎,其中 49.9%的病例开具了抗菌药物。广谱抗菌药物是主要的处方药物,占所有年龄组处方的近 90%。我们的数据表明,在门诊治疗 ARTI 方面,抗菌药物的处方比例或定量方面有一个有利的实践。然而,从定性角度来看,处方偏向于广谱抗菌药物,这突出表明需要在门诊环境中进一步进行抗菌药物管理。